Biogened S.A. (WSE:BGD)
24.30
+0.39 (1.64%)
At close: Sep 10, 2025
Biogened Revenue
Biogened had revenue of 29.26M PLN in the quarter ending June 30, 2025, a decrease of -4.69%. This brings the company's revenue in the last twelve months to 112.75M, up 6.61% year-over-year. In the year 2024, Biogened had annual revenue of 110.93M with 16.09% growth.
Revenue (ttm)
112.75M
Revenue Growth
+6.61%
P/S Ratio
0.52
Revenue / Employee
536.91K
Employees
227
Market Cap
58.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 110.93M | 15.37M | 16.09% |
Dec 31, 2023 | 95.56M | 15.94M | 20.02% |
Dec 31, 2022 | 79.62M | 14.30M | 21.89% |
Dec 31, 2021 | 65.32M | 16.99M | 35.15% |
Dec 31, 2020 | 48.33M | 1.70M | 3.64% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Orlen | 277.33B |
Powszechna Kasa Oszczednosci Bank Polski Spólka Akcyjna | 28.99B |
Powszechny Zaklad Ubezpieczen | 62.88B |
Santander Bank Polska | 16.87B |
Bank Polska Kasa Opieki | 15.61B |
Dino Polska | 31.34B |
ING Bank Slaski | 10.21B |
mBank | 12.17B |